SubPopulations and InteRmediate Outcome Measures In COPD Study

SPIROMICS STEERING COMMITTEE MEETING

UNIVERSITY OF UTAH HEALTH
SALT LAKE CITY, UTAH

APRIL 4-5, 2019

The Steering Committee meeting on Thursday, 04/04 is remote open invitation to include Industry and Academic Partners via Zoom.

Join by Zoom: from PC, Mac, Linux, iOS or Android: http://unc.zoom.us/j/992109824
Join by Phone: 1-646-558-8656 or Global call-in numbers, Meeting ID: 992 109 824

The Steering Committee meeting on Friday, 04/05 is closed to SPIROMICS Investigators only.

RSVP / Questions: spiromics@unc.edu

Photo for Site Spotlight on Columbia University Medical Center

SPIROMICS VIEWS WEB CHARTS

This web-based application allows users to view up-
to-date, interactive graphical displays of recruitment,
study management, and quality control.

Views Web Charts

For more information about how to log in and use the web charts, a memo and reference guide are available.

Please contact the GIC at spiromics@unc.edu with any questions.

Recent SPIROMICS Publications

Systemic markers of inflammation in smokers with symptoms despite preserved spirometry in SPIROMICS. -- Chest

Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study. -- Chest

Heterogeneous burden of lung disease in smokers with borderline airflow obstruction. -- Respir Res

Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene. -- JCI Insight